"Promover, favorecer, impulsar, realizar, apoyar, y financiar las actividades de investigación, docencia, formación, divulgación, y promoción en relación con la enfermedad de Alzheimer y otras enfermedades degenerativas."

During the past decade, Fundacion CITA ALZHEIMER conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion CITA ALZHEIMER" #1 collaborator was "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion CITA ALZHEIMER" are "Alzheimer´s Disease" (1 trials), "Early Preclinical Alzheimer's Disease" (1 trials) and "Preclinical Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Fundacion CITA ALZHEIMER" in a lesser frequency.

Most popular intervention types in "Fundacion CITA ALZHEIMER" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lanabecestat" (1 trials) and "Lecanemab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion CITA ALZHEIMER" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion CITA ALZHEIMER". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fundacion CITA ALZHEIMER, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion CITA ALZHEIMER, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".